ARCHIVES

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

Rall, FDA Chief On AACR Panel

April 27, 1979

Bahama Government Closes Clinic “Immediately And Permanently” After AIDs Contamination Report

July 26, 1985

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002

Long-time NCI Spokesman Paul Van Nevel Dies at 75

August 9, 2013

Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget.

January 14, 2005